N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA)

Progress in Lipid Research

Volumn 49, Issue 4, 2010, Pages 299-315

  Ueda, Natsuo ^a   Tsuboi, Kazuhito ^a   Uyama, Toru ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Anandamide; Endocannabinoid; N acylphosphatidylethanolamine; Phospholipase; Phospholipid

Indexed keywords

ACID CERAMIDASE; ANANDAMIDE; CALCIUM DEPENDENT N ACYLTRANSFERASE; CALCIUM INDEPENDENT N ACYLTRANSFERASE; CALCIUM ION; CANNABINOID RECEPTOR; FATTY ACID AMIDASE; GLYCEROPHOSPHOLIPID; LECITHIN RETINOL ACYLTRANSFERASE; LYSOSOME ENZYME; N ACYLETHANOLAMINE; N ACYLETHANOLAMINE HYDROLYZING ACID AMIDASE; N ACYLPHOSPHATIDYLETHANOLAMINE; N ACYLTRANSFERASE; PHOSPHATIDYLETHANOLAMINE; PHOSPHODIESTERASE; PHOSPHOLIPASE D; PROTEIN H REV107; TRANSFERASE; UNCLASSIFIED DRUG;

ACYLATION; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BRAIN; CELLULAR DISTRIBUTION; DEACYLATION; ENZYME SUBSTRATE; FERTILITY; GLYCOSYLATION; HUMAN; HYDROLYSIS; MACROPHAGE; MEMBRANE COMPONENT; N ACYLETHANOLAMINE BIOSYNTHESIS; NONHUMAN; ONCOGENE H RAS; PH; PHOSPHOLIPID METABOLISM; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN STRUCTURE; REVIEW; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SOLUBILIZATION; TISSUE DISTRIBUTION; TRANSACYLATION; TUMOR SUPPRESSOR GENE;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; CELL LINE; ENDOCANNABINOIDS; ETHANOLAMINES; MOLECULAR STRUCTURE; PHOSPHOLIPASE D; POLYUNSATURATED ALKAMIDES;

ANIMALIA; MAMMALIA;

EID: 77956393864     PISSN: 01637827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plipres.2010.02.003     Document Type: Review

References (203)

1. F.A. Kuehl Jr., T.A. Jacob, O.H. Ganley, R.E. Ormond, and M.A.P. Meisinger The identification of N-(2-hydroxyethyl)-palmitamide as a naturally occurring anti-inflammatory agent J Am Chem Soc 79 1957 5577 5578
2. N.R. Bachur, K. Masek, K.L. Melmon, and S. Udenfriend Fatty acid amides of ethanolamine in mammalian tissues J Biol Chem 240 1965 1019 1024
3. O.H. Ganley, O.E. Graessle, and H.J. Robinson Anti-inflammatory activity on compounds obtained from egg yolk, peanut oil, and soybean lecithin J Lab Clin Med 51 1958 709 714
4. H.H.O. Schmid, P.C. Schmid, and V. Natarajan N-acylated glycerophospholipids and their derivatives Prog Lipid Res 29 1990 1 43
5. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, and G. Griffin Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949
6. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
7. V. Di Marzo 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance Biochim Biophys Acta 1392 1998 153 175
8. A.C. Howlett, and S. Mukhopadhyay Cellular signal transduction by anandamide and 2-arachidonoylglycerol Chem Phys Lipids 108 2000 53 70
9. P. Pacher, S. Bátkai, and G. Kunos The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol Rev 58 2006 389 462
10. L. Hanus, A. Gopher, S. Almog, and R. Mechoulam Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor J Med Chem 36 1993 3032 3034
11. J. Priller, E.M. Briley, J. Mansouri, W.A. Devane, K. Mackie, and C.C. Felder Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors Mol Pharmacol 48 1995 288 292
12. C.C. Felder, E.M. Briley, J. Axelrod, J.T. Simpson, K. Mackie, and W.A. Devane Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction Proc Natl Acad Sci USA 90 1993 7656 7660
13. T. Sugiura, S. Kishimoto, S. Oka, and M. Gokoh Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand Prog Lipid Res 45 2006 405 446
14. M. van der Stelt, and V. Di Marzo Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels Eur J Biochem 271 2004 1827 1834
15. R. Mechoulam, S. Ben-Shabat, L. Hanus, M. Ligumsky, N.E. Kaminski, and A.R. Schatz Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem Pharmacol 50 1995 83 90
16. T. Sugiura, S. Kondo, A. Sukagawa, S. Nakane, A. Shinoda, and K. Itoh 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem Biophys Res Commun 215 1995 89 97
17. D.M. Lambert, S. Vandevoorde, K.O. Jonsson, and C.J. Fowler The palmitoylethanolamide family: a new class of anti-inflammatory agents? Curr Med Chem 9 2002 663 674
18. F. Rodríguez de Fonseca, M. Navarro, R. Gómez, L. Escuredo, F. Nava, and J. Fu An anorexic lipid mediator regulated by feeding Nature 414 2001 209 212
19. J. Lo Verme, S. Gaetani, J. Fu, F. Oveisi, K. Burton, and D. Piomelli Regulation of food intake by oleoylethanolamide Cell Mol Life Sci 62 2005 708 716
20. G. Astarita, B. Di Giacomo, S. Gaetani, F. Oveisi, T.R. Compton, and S. Rivara Pharmacological characterization of hydrolysis-resistant analogs of oleoylethanolamide with potent anorexiant properties J Pharmacol Exp Ther 318 2006 563 570
21. J. Fu, S. Gaetani, F. Oveisi, J. Lo Verme, A. Serrano, and F. Rodríguez De Fonseca Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α Nature 425 2003 90 93
22. J. Lo Verme, J. Fu, G. Astarita, G. La Rana, R. Russo, and A. Calignano The nuclear receptor peroxisome proliferator-activated receptor-α mediates the anti-inflammatory actions of palmitoylethanolamide Mol Pharmacol 67 2005 15 19
23. H.A. Overton, A.J. Babbs, S.M. Doel, M.C.T. Fyfe, L.S. Gardner, and G. Griffin Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents Cell Metab 3 2006 167 175
24. R.A. Ross The enigmatic pharmacology of GPR55 Trends Pharmacol Sci 30 2009 156 163
25. S. Oka, T. Toshida, K. Maruyama, K. Nakajima, A. Yamashita, and T. Sugiura 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55 J Biochem 145 2009 13 20
26. M.P. Gillum, D. Zhang, X.-M. Zhang, D.M. Erion, R.A. Jamison, and C. Choi N-acylphosphatidylethanolamine, a gut-derived circulating factor induced by fat ingestion, inhibits food intake Cell 135 2008 813 824
27. A. Shiratsuchi, M. Ichiki, Y. Okamoto, N. Ueda, N. Sugimoto, and Y. Takuwa Inhibitory effect of N-palmitoylphosphatidylethanolamine on macrophage phagocytosis through inhibition of Rac1 and Cdc42 J Biochem 145 2009 43 50
28. V. Di Marzo Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7 2008 438 455
29. 2+-independent phosphatidylethanolamine N-acyltransferase generating the anandamide precursor and its congeners J Biol Chem 282 2007 3614 3623
30. V. Natarajan, P.V. Reddy, P.C. Schmid, and H.H.O. Schmid N-acylation of ethanolamine phospholipids in canine myocardium Biochim Biophys Acta 712 1982 342 355
31. P.V. Reddy, V. Natarajan, P.C. Schmid, and H.H.O. Schmid N-acylation of dog heart ethanolamine phospholipids by transacylase activity Biochim Biophys Acta 750 1983 472 480
32. P.V. Reddy, P.C. Schmid, V. Natarajan, and H.H.O. Schmid The role of cardiolipin as an acyl donor in dog heart N-acylethanolamine phospholipid biosynthesis Biochim Biophys Acta 751 1983 241 246
33. P.V. Reddy, P.C. Schmid, V. Natarajan, T. Muramatsu, and H.H.O. Schmid Properties of canine myocardial phosphatidylethanolamine N-acyltransferase Biochim Biophys Acta 795 1984 130 136
34. V. Natarajan, P.C. Schmid, P.V. Reddy, M.L. Zuzarte-Augustin, and H.H.O. Schmid Biosynthesis of N-acylethanolamine phospholipids by dog brain preparations J Neurochem 41 1983 1303 1312
35. V. Natarajan, P.C. Schmid, and H.H.O. Schmid N-acylethanolamine phospholipid metabolism in normal and ischemic rat brain Biochim Biophys Acta 878 1986 32 41
36. H. Cadas, E. di Tomaso, and D. Piomelli Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain J Neurosci 17 1997 1226 1242
37. T. Sugiura, S. Kondo, A. Sukagawa, T. Tonegawa, S. Nakane, and A. Yamashita Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine Eur J Biochem 240 1996 53 62
38. 2+-dependent transacylase and phosphodiesterase activities Biochem Biophys Res Commun 218 1996 113 117
39. H.S. Hansen, B. Moesgaard, H.H. Hansen, and G. Petersen N-acylethanolamines and precursor phospholipids - relation to cell injury Chem Phys Lipids 108 2000 135 150
40. H.H.O. Schmid Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively? Chem Phys Lipids 108 2000 71 87
41. H.U. Shetty, Q.R. Smith, K. Washizaki, S.I. Rapoport, and A.D. Purdon Identification of two molecular species of rat brain phosphatidylcholine that rapidly incorporate and turn over arachidonic acid in vivo J Neurochem 67 1996 1702 1710
42. G. Astarita, F. Ahmed, and D. Piomelli Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain J Lipid Res 49 2008 48 57
43. D.E. Epps, P.C. Schmid, V. Natarajan, and H.H.O. Schmid N-acylethanolamine accumulation in infarcted myocardium Biochem Biophys Res Commun 90 1979 628 633
44. D.E. Epps, V. Natarajan, P.C. Schmid, and H.H.O. Schmid Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium Biochim Biophys Acta 618 1980 420 430
45. P.C. Schmid, R.J. Krebsbach, S.R. Perry, T.M. Dettmer, J.L. Maasson, and H.H.O. Schmid Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain FEBS Lett 375 1995 117 120
46. 31P NMR and enzyme activity study J Lipid Res 41 2000 985 990
47. S. Kondo, T. Sugiura, T. Kodaka, N. Kudo, K. Waku, and A. Tokumura Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis Arch Biochem Biophys 354 1998 303 310
48. H.S. Hansen, L. Lauritzen, A.M. Strand, B. Moesgaard, and A. Frandsen Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cortical neurons in culture Biochim Biophys Acta 1258 1995 303 308
49. + cells Biochem J 346 2000 369 374
50. H. Cadas, S. Gaillet, M. Beltramo, L. Venance, and D. Piomelli Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP J Neurosci 16 1996 3934 3942
51. B. Moesgaard, H.H. Hansen, S.L. Hansen, S.H. Hansen, G. Petersen, and H.S. Hansen Brain levels of N-acylethanolamine phospholipids in mice during pentylenetetrazol-induced seizure Lipids 38 2003 387 390
52. B. Moesgaard, G. Petersen, S.A. Mortensen, and H.S. Hansen Substantial species differences in relation to formation and degradation of N-acyl-ethanolamine phospholipids in heart tissue: an enzyme activity study Comp Biochem Physiol B Biochem Mol Biol 131 2002 475 482
53. A. Ruiz, A. Winston, Y.-H. Lim, B.A. Gilbert, R.R. Rando, and D. Bok Molecular and biochemical characterization of lecithin retinol acyltransferase J Biol Chem 274 1999 3834 3841
54. R. Zolfaghari, and A.C. Ross Lecithin:retinol acyltransferase from mouse and rat liver: cDNA cloning and liver-specific regulation by dietary vitamin A and retinoic acid J Lipid Res 41 2000 2024 2034
55. R.R. Rando Membrane-bound lecithin-retinol acyltransferase Biochem Biophys Res Commun 292 2002 1243 1250
56. M. Golczak, Y. Imanishi, V. Kuksa, T. Maeda, R. Kubota, and K. Palczewski Lecithin:retinol acyltransferase is responsible for amidation of retinylamine, a potent inhibitor of the retinoid cycle J Biol Chem 280 2005 42263 42273
57. V. Anantharaman, and L. Aravind Evolutionary history, structural features and biochemical diversity of the NlpC/P60 superfamily of enzymes Genome Biol 4 2003 R11
58. W.J. Jahng, L. Xue, and R.R. Rando Lecithin retinol acyltransferase is a founder member of a novel family of enzymes Biochemistry 42 2003 12805 12812
59. 2+-independent phosphatidylethanolamine N-acyltransferases Biochim Biophys Acta 1791 2009 32 38
60. Y. Yamano, A. Asano, K. Ohyama, M. Ohta, R. Nishio, and I. Morishima Expression of the Ha-ras suppressor family member 5 gene in the maturing rat testis Biosci Biotechnol Biochem 72 2008 1360 1363
61. Y.Q. Shi, I. Hubacek, and R.R. Rando Kinetic mechanism of lecithin retinol acyl transferase Biochemistry 32 1993 1257 1263
62. A. Hajnal, R. Klemenz, and R. Schäfer Subtraction cloning of H-rev107, a gene specifically expressed in H-ras resistant fibroblasts Oncogene 9 1994 479 490
63. C. Sers, U. Emmenegger, K. Husmann, K. Bucher, A.C. Andres, and R. Schäfer Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors J Cell Biol 136 1997 935 944
64. K. Roder, K.-H. Kim, and H.S. Sul Induction of murine H-rev107 gene expression by growth arrest and histone acetylation: involvement of an Sp1/Sp3-binding GC-box Biochem Biophys Res Commun 294 2002 63 70
65. 1/2 of the thiol hydrolase-type J Lipid Res 50 2009 685 693
66. 2 (AdPLA) J Biol Chem 283 2008 25428 25436
67. K. Jaworski, M. Ahmadian, R.E. Duncan, E. Sarkadi-Nagy, K.A. Varady, and M.K. Hellerstein AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency Nat Med 15 2009 159 168
68. R.-Y. Shyu, Y.-C. Hsieh, F.-M. Tsai, C.-C. Wu, and S.-Y. Jiang Cloning and functional characterization of the HRASLS2 gene Amino Acids 35 2009 129 137
69. D. Disepio, C. Ghosn, R.L. Eckert, A. Deucher, N. Robinson, and M. Duvic Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene Proc Natl Acad Sci USA 95 1998 14811 14815
70. F.-M. Tsai, R.-Y. Shyu, and S.-Y. Jiang RIG1 suppresses Ras activation and induces cellular apoptosis at the Golgi apparatus Cell Signal 19 2007 989 999
71. T. Uyama, X.-H. Jin, K. Tsuboi, T. Tonai, and N. Ueda Characterization of the human tumor suppressors TIG3 and HRASLS2 as phospholipid-metabolizing enzymes Biochim Biophys Acta 1791 2009 1114 1124
72. N. Ueda, Y. Okamoto, and K. Tsuboi Endocannabinoid-related enzymes as drug targets with special reference to N-acylphosphatidylethanolamine- hydrolyzing phospholipase D Curr Med Chem 12 2005 1413 1422
73. Y. Okamoto, J. Wang, J. Morishita, and N. Ueda Biosynthetic pathways of the endocannabinoid anandamide Chem Biodivers 4 2007 1842 1857
74. J. Wang, and N. Ueda Biology of endocannabinoid synthesis system Prostaglandins Other Lipid Mediat 89 2009 112 119
75. V. Natarajan, P.V. Reddy, P.C. Schmid, and H.H.O. Schmid On the biosynthesis and metabolism of N-acylethanolamine phospholipids in infarcted dog heart Biochim Biophys Acta 664 1981 445 448
76. P.C. Schmid, P.V. Reddy, V. Natarajan, and H.H.O. Schmid Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type J Biol Chem 258 1983 9302 9306
77. G. Petersen, and H.S. Hansen N-acylphosphatidylethanolamine-hydrolysing phospholipase D lacks the ability to transphosphatidylate FEBS Lett 455 1999 41 44
78. V. Natarajan, P.C. Schmid, P.V. Reddy, and H.H.O. Schmid Catabolism of N-acylethanolamine phospholipids by dog brain preparations J Neurochem 42 1984 1613 1619
79. N. Ueda, Q. Liu, and K. Yamanaka Marked activation of the N-acylphosphatidylethanolamine-hydrolyzing phosphodiesterase by divalent cations Biochim Biophys Acta 1532 2001 121 127
80. Q. Liu, T. Tonai, and N. Ueda Activation of N-acylethanolamine-releasing phospholipase D by polyamines Chem Phys Lipids 115 2002 77 84
81. Y. Okamoto, J. Morishita, K. Tsuboi, T. Tonai, and N. Ueda Molecular characterization of a phospholipase D generating anandamide and its congeners J Biol Chem 279 2004 5298 5305
82. D. Leung, A. Saghatelian, G.M. Simon, and B.F. Cravatt Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids Biochemistry 45 2006 4720 4726
83. N. Ueda, Y. Okamoto, and J. Morishita N-acylphosphatidylethanolamine- hydrolyzing phospholipase D: a novel enzyme of the β-lactamase fold family releasing anandamide and other N-acylethanolamines Life Sci 77 2005 1750 1758
84. O. Merkel, P.C. Schmid, F. Paltauf, and H.H.O. Schmid Presence and potential signaling function of N-acylethanolamines and their phospholipid precursors in the yeast Saccharomyces cerevisiae Biochim Biophys Acta 1734 2005 215 219
85. J.M. McPartland, I. Matias, V. Di Marzo, and M. Glass Evolutionary origins of the endocannabinoid system Gene 370 2006 64 74
86. N.P. Curtiss, J.M. Bonifas, J.O. Lauchle, J.D. Balkman, C.P. Kratz, and B.M. Emerling Isolation and analysis of candidate myeloid tumor suppressor genes from a commonly deleted segment of 7q22 Genomics 85 2005 600 607
87. M. Liscovitch, M. Czarny, G. Fiucci, and X. Tang Phospholipase D: molecular and cell biology of a novel gene family Biochem J 345 2000 401 415
88. S.M. Hammond, Y.M. Altshuller, T.-C. Sung, S.A. Rudge, K. Rose, and J. Engebrecht Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family J Biol Chem 270 1995 29640 29643
89. W.C. Colley, T.-C. Sung, R. Roll, J. Jenco, S.M. Hammond, and Y. Altshuller Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization Curr Biol 7 1997 191 201
90. 2+-dependent phospholipase D Protein Sci 11 2002 2958 2968
91. 2 and D: a method of identification and analysis Chem Phys Lipids 41 1986 195 207
92. L. Aravind An evolutionary classification of the metallo-beta-lactamase fold proteins In Silico Biol 1 1999 69 91
93. H. Daiyasu, K. Osaka, Y. Ishino, and H. Toh Expansion of the zinc metallo-hydrolase family of the β-lactamase fold FEBS Lett 503 2001 1 6
94. J. Wang, Y. Okamoto, J. Morishita, K. Tsuboi, A. Miyatake, and N. Ueda Functional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-β-lactamase family J Biol Chem 281 2006 12325 12335
95. Z. Wang, W. Fast, A.M. Valentine, and S.J. Benkovic Metallo-β- lactamase: structure and mechanism Curr Opin Chem Biol 3 1999 614 622
96. T. Sasaki, and M.C. Chang N-arachidonylethanolamine (anandamide) formation from N-arachidonylphosphatidylethanolamine in rat brain membranes Life Sci 61 1997 1803 1810
97. J. Morishita, Y. Okamoto, K. Tsuboi, M. Ueno, H. Sakamoto, and N. Maekawa Regional distribution and age-dependent expression of N- acylphosphatidylethanolamine-hydrolyzing phospholipase D in rat brain J Neurochem 94 2005 753 762
98. J. Wang, Y. Okamoto, K. Tsuboi, and N. Ueda The stimulatory effect of phosphatidylethanolamine on N-acylphosphatidylethanolamine-hydrolyzing phospholipase D (NAPE-PLD) Neuropharmacology 54 2008 8 15
99. G. Petersen, A.H. Pedersen, D.S. Pickering, M. Begtrup, and H.S. Hansen Effect of synthetic and natural phospholipids on N-acylphosphatidylethanolamine- hydrolyzing phospholipase D activity Chem Phys Lipids 162 2009 53 61
100. G. Petersen, K.D. Chapman, and H.S. Hansen A rapid phospholipase D assay using zirconium precipitation of anionic substrate phospholipids: application to N-acylethanolamine formation in vitro J Lipid Res 41 2000 1532 1538
101. M. Egertová, G.M. Simon, B.F. Cravatt, and M.R. Elphick Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: a new perspective on N-acylethanolamines as neural signaling molecules J Comp Neurol 506 2008 604 615
102. L. Cristino, K. Starowicz, L. De Petrocellis, J. Morishita, N. Ueda, and V. Guglielmotti Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain Neuroscience 151 2008 955 968
103. R. Nyilas, B. Dudok, G.M. Urban, K. Mackie, M. Watanabe, and B.F. Cravatt Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals J Neurosci 28 2008 1058 1063
104. M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe Endocannabinoid-mediated control of synaptic transmission Physiol Rev 89 2009 309 380
105. H. Schuel, L.J. Burkman, J. Lippes, K. Crickard, E. Forester, and D. Piomelli N-acylethanolamines in human reproductive fluids Chem Phys Lipids 121 2002 211 227
106. Y. Guo, H. Wang, Y. Okamoto, N. Ueda, P.J. Kingsley, and L.J. Marnett N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation J Biol Chem 280 2005 23429 23432
107. M. Maccarrone, B. Barboni, A. Paradisi, N. Bernab, V. Gasperi, and M.G. Pistilli Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction J Cell Sci 118 2005 4393 4404
108. H. Wang, H. Xie, Y. Guo, H. Zhang, T. Takahashi, and P.J. Kingsley Fatty acid amide hydrolase deficiency limits early pregnancy events J Clin Invest 116 2006 2122 2131
109. J. Wang, L.-Y. Zhao, T. Uyama, K. Tsuboi, X.-X. Wu, and Y. Kakehi Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells J Biochem 144 2008 685 690
110. 2 and lysophospholipase D Biochem J 380 2004 749 756
111. G.M. Simon, and B.F. Cravatt Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for α/β- hydrolase 4 in this pathway J Biol Chem 281 2006 26465 26472
112. G.M. Simon, and B.F. Cravatt Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain J Biol Chem 283 2008 9341 9349
113. B. Zheng, C.P. Berrie, D. Corda, and M.G. Farquhar GDE1/MIR16 is a glycerophosphoinositol phosphodiesterase regulated by stimulation of G protein-coupled receptors Proc Natl Acad Sci USA 100 2003 1745 1750
114. J. Liu, L. Wang, J. Harvey-White, D. Osei-Hyiaman, R. Razdan, and Q. Gong A biosynthetic pathway for anandamide Proc Natl Acad Sci USA 103 2006 13345 13350
115. J. Liu, L. Wang, J. Harvey-White, B.X. Huang, H.-Y. Kim, and S. Luquet Multiple pathways involved in the biosynthesis of anandamide Neuropharmacology 54 2008 1 7
116. N. Ueda, R.A. Puffenbarger, S. Yamamoto, and D.G. Deutsch The fatty acid amide hydrolase (FAAH) Chem Phys Lipids 108 2000 107 121
117. M.P. Patricelli, and B.F. Cravatt Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides Vitam Horm 62 2001 95 131
118. N. Ueda Endocannabinoid hydrolases Prostaglandins Other Lipid Mediat 68-69 2002 521 534
119. B.F. Cravatt, and A.H. Lichtman The enzymatic inactivation of the fatty acid amide class of signaling lipids Chem Phys Lipids 121 2002 135 148
120. D.G. Deutsch, N. Ueda, and S. Yamamoto The fatty acid amide hydrolase (FAAH) Prostaglandins Leukot Essent Fatty Acids 66 2002 201 210 [Erratum in: Prostaglandins Leukot Essent Fatty Acids 2003;68:69]
121. M.K. McKinney, and B.F. Cravatt Structure and function of fatty acid amide hydrolase Annu Rev Biochem 74 2005 411 432
122. G. Labar, and C. Michaux Fatty acid amide hydrolase: from characterization to therapeutics Chem Biodivers 4 2007 1882 1902
123. P.C. Schmid, M.L. Zuzarte-Augustin, and H.H.O. Schmid Properties of rat liver N-acylethanolamine amidohydrolase J Biol Chem 260 1985 14145 14149
124. D.G. Deutsch, and S.A. Chin Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist Biochem Pharmacol 46 1993 791 796
125. F. Desarnaud, H. Cadas, and D. Piomelli Anandamide amidohydrolase activity in rat brain microsomes Identification and partial characterization J Biol Chem 270 1995 6030 6035
126. N. Ueda, Y. Kurahashi, S. Yamamoto, and T. Tokunaga Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide J Biol Chem 270 1995 23823 23827
127. B.F. Cravatt, D.K. Giang, S.P. Mayfield, D.L. Boger, R.A. Lerner, and N.B. Gilula Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 384 1996 83 87
128. K. Katayama, N. Ueda, Y. Kurahashi, H. Suzuki, S. Yamamoto, and I. Kato Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine Biochim Biophys Acta 1347 1997 212 218
129. Y.-X. Sun, K. Tsuboi, L.-Y. Zhao, Y. Okamoto, D.M. Lambert, and N. Ueda Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages Biochim Biophys Acta 1736 2005 211 220
130. S.J. Reilly, E.M. O'Shea, U. Andersson, J. O'Byrne, S.E. Alexson, and M.C. Hunt A peroxisomal acyltransferase in mouse identifies a novel pathway for taurine conjugation of fatty acids FASEB J 21 2007 99 107
131. D.K. Giang, and B.F. Cravatt Molecular characterization of human and mouse fatty acid amide hydrolases Proc Natl Acad Sci USA 94 1997 2238 2242
132. B.Q. Wei, T.S. Mikkelsen, M.K. McKinney, E.S. Lander, and B.F. Cravatt A second fatty acid amide hydrolase with variable distribution among placental mammals J Biol Chem 281 2006 36569 36578
133. S.K. Goparaju, Y. Kurahashi, H. Suzuki, N. Ueda, and S. Yamamoto Anandamide amidohydrolase of porcine brain: cDNA cloning, functional expression and site-directed mutagenesis Biochim Biophys Acta 1441 1999 77 84
134. M.P. Patricelli, M.A. Lovato, and B.F. Cravatt Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties Biochemistry 38 1999 9804 9812
135. M.K. McKinney, and B.F. Cravatt Evidence for distinct roles in catalysis for residues of the serine-serine-lysine catalytic triad of fatty acid amide hydrolase J Biol Chem 278 2003 37393 37399
136. M.H. Bracey, M.A. Hanson, K.R. Masuda, R.C. Stevens, and B.F. Cravatt Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling Science 298 2002 1793 1796
137. S. Maurelli, T. Bisogno, L. De Petrocellis, A. Di Luccia, G. Marino, and V. Di Marzo Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma 'anandamide amidohydrolase' FEBS Lett 377 1995 82 86
138. A. Saghatelian, S.A. Trauger, E.J. Want, E.G. Hawkins, G. Siuzdak, and B.F. Cravatt Assignment of endogenous substrates to enzymes by global metabolite profiling Biochemistry 43 2004 14332 14339
139. S.K. Goparaju, N. Ueda, H. Yamaguchi, and S. Yamamoto Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand FEBS Lett 422 1998 69 73
140. J.L. Blankman, G.M. Simon, and B.F. Cravatt A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol Chem Biol 14 2007 1347 1356
141. K.K. Kruszka, and R.W. Gross The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor J Biol Chem 269 1994 14345 14348
142. W.A. Devane, and J. Axelrod Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes Proc Natl Acad Sci USA 91 1994 6698 6701
143. G. Arreaza, W.A. Devane, R.L. Omeir, G. Sajnani, J. Kunz, and B.F. Cravatt The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine Neurosci Lett 234 1997 59 62
144. Y. Kurahashi, N. Ueda, H. Suzuki, M. Suzuki, and S. Yamamoto Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase Biochem Biophys Res Commun 237 1997 512 515
145. K. Katayama, N. Ueda, I. Katoh, and S. Yamamoto Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme Biochim Biophys Acta 1440 1999 205 214
146. M. Kaczocha, S.T. Glaser, J. Chae, D.A. Brown, and D.G. Deutsch Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2 J Biol Chem 285 2010 2796 2806
147. B.F. Cravatt, K. Demarest, M. Patricelli, M.H. Bracey, D.K. Giang, and B.R. Martin Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase Proc Natl Acad Sci USA 98 2001 9371 9376
148. A.B. Clement, E.G. Hawkins, A.H. Lichtman, and B.F. Cravatt Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase J Neurosci 23 2003 3916 3923
149. S. Kathuria, S. Gaetani, D. Fegley, F. Valiño, A. Duranti, and A. Tontini Modulation of anxiety through blockade of anandamide hydrolysis Nat Med 9 2003 76 81
150. A.H. Lichtman, D. Leung, C.C. Shelton, A. Saghatelian, C. Hardouin, and D.L. Boger Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity J Pharmacol Exp Ther 311 2004 441 448
151. K. Ahn, D.S. Johnson, M. Mileni, D. Beidler, J.Z. Long, and M.K. McKinney Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain Chem Biol 16 2009 411 420
152. S.H. Burstein, R.G. Rossetti, B. Yagen, and R.B. Zurier Oxidative metabolism of anandamide Prostaglandins Other Lipid Mediat 61 2000 29 41
153. K.R. Kozak, and L.J. Marnett Oxidative metabolism of endocannabinoids Prostaglandins Leukot Essent Fatty Acids 66 2002 211 220
154. S. Vandevoorde, and D.M. Lambert The multiple pathways of endocannabinoid metabolism: a zoom out Chem Biodivers 4 2007 1858 1881
155. C.J. Fowler The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action Brit J Pharmacol 152 2007 594 601
156. N. Ueda, K. Yamamoto, S. Yamamoto, T. Tokunaga, E. Shirakawa, and H. Shinkai Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist Biochim Biophys Acta 1254 1995 127 134
157. A.J. Hampson, W.A.G. Hill, M. Zan-Phillips, A. Makriyannis, E. Leung, and R.M. Eglen Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor Biochim Biophys Acta 1259 1995 173 179
158. M. van der Stelt, W.F. Nieuwenhuizen, G.A. Veldink, and J.F.G. Vliegenthart Dioxygenation of N-linoleoyl amides by soybean lipoxygenase-1 FEBS Lett 411 1997 287 290
159. M. van der Stelt, M.A. Noordermeer, T. Kiss, G. van Zadelhoff, B. Merghart, and G.A. Veldink Formation of a new class of oxylipins from N-acyl(ethanol)amines by the lipoxygenase pathway Eur J Biochem 267 2000 2000 2007
160. 2 ethanolamide from anandamide by cyclooxygenase-2 J Biol Chem 272 1997 21181 21186
161. K.R. Kozak, B.C. Crews, J.D. Morrow, L.H. Wang, Y.H. Ma, and R. Weinander Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides J Biol Chem 277 2002 44877 44885
162. L.M. Bornheim, K.Y. Kim, B. Chen, and M.A. Correia The effect of cannabidiol on mouse hepatic microsomal cytochrome P450-dependent anandamide metabolism Biochem Biophys Res Commun 197 1993 740 746
163. N.T. Snider, M.J. Sikora, C. Sridar, T.J. Feuerstein, J.M. Rae, and P.F. Hollenberg The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6 J Pharmacol Exp Ther 327 2008 538 545
164. K. Stark, M. Dostalek, and F.P. Guengerich Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide FEBS J 275 2008 3706 3717
165. K.R. Kozak, B.C. Crews, J.L. Ray, H.-H. Tai, J.D. Morrow, and L.J. Marnett Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo J Biol Chem 276 2001 36993 36998
166. A. Weber, J. Ni, K.H. Ling, A. Acheampong, D.D. Tang-Liu, and R. Burk Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry J Lipid Res 45 2004 757 763
167. A.M. Mulder, and B.F. Cravatt Endocannabinoid metabolism in the absence of fatty acid amide hydrolase (FAAH): discovery of phosphorylcholine derivatives of N-acyl ethanolamines Biochemistry 45 2006 11267 11277
168. N. Ueda, K. Yamanaka, Y. Terasawa, and S. Yamamoto An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors FEBS Lett 454 1999 267 270
169. N. Ueda, K. Yamanaka, and S. Yamamoto Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance J Biol Chem 276 2001 35552 35557
170. K. Tsuboi, Y.-X. Sun, Y. Okamoto, N. Araki, T. Tonai, and N. Ueda Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase J Biol Chem 280 2005 11082 11092
171. K. Tsuboi, L.-Y. Zhao, Y. Okamoto, N. Araki, M. Ueno, and H. Sakamoto Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies Biochim Biophys Acta 1771 2007 623 632
172. S.-B. Hong, C.-M. Li, H.-J. Rhee, J.-H. Park, X. He, and B. Levy Molecular cloning and characterization of a human cDNA and gene encoding a novel acid ceramidase-like protein Genomics 62 1999 232 241
173. K. Tsuboi, N. Takezaki, and N. Ueda The N-acylethanolamine-hydrolyzing acid amidase (NAAA) Chem Biodivers 4 2007 1914 1925
174. M. Rossocha, R. Schultz-Heienbrok, H. von Moeller, J.P. Coleman, and W. Saenger Conjugated bile acid hydrolase is a tetrameric N-terminal thiol hydrolase with specific recognition of its cholyl but not of its tauryl product Biochemistry 44 2005 5739 5748
175. R.S. Kumar, J.A. Brannigan, A.A. Prabhune, A.V. Pundle, G.G. Dodson, and E.J. Dodson Structural and functional analysis of a conjugated bile salt hydrolase from Bifidobacterium longum reveals an evolutionary relationship with penicillin V acylase J Biol Chem 281 2006 32516 32525
176. C.G. Suresh, A.V. Pundle, H. SivaRaman, K.N. Rao, J.A. Brannigan, and C.E. McVey Penicillin V acylase crystal structure reveals new Ntn-hydrolase family members Nat Struct Biol 6 1999 414 416
177. J. Wang, L.-Y. Zhao, T. Uyama, K. Tsuboi, T. Tonai, and N. Ueda Amino acid residues crucial in pH regulation and proteolytic activation of N-acylethanolamine-hydrolyzing acid amidase Biochim Biophys Acta 1781 2008 710 717
178. J. Koch, S. Gärtner, C.-M. Li, L.E. Quintern, K. Bernardo, and O. Levran Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification of the first molecular lesion causing Farber disease J Biol Chem 271 1996 33110 33115
179. L.-Y. Zhao, K. Tsuboi, Y. Okamoto, S. Nagahata, and N. Ueda Proteolytic activation and glycosylation of N-acylethanolamine-hydrolyzing acid amidase, a lysosomal enzyme involved in the endocannabinoid metabolism Biochim Biophys Acta 1771 2007 1397 1405
180. C. Oinonen, and J. Rouvinen Structural comparison of Ntn-hydrolases Protein Sci 9 2000 2329 2337
181. L. Mach, J.S. Mort, and J. Glössl Maturation of human procathepsin B. Proenzyme activation and proteolytic processing of the precursor to the mature proteinase, in vitro, are primarily unimolecular processes J Biol Chem 269 1994 13030 13035
182. K. Ishidoh, and E. Kominami Multi-step processing of procathepsin L in vitro FEBS Lett 352 1994 281 284
183. L. Lin, I. Sohar, H. Lackland, and P. Lobel The human CLN2 protein/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH J Biol Chem 276 2001 2249 2255
184. N. Shtraizent, E. Eliyahu, J.-H. Park, X. He, R. Shalgi, and E.H. Schuchman Autoproteolytic cleavage and activation of human acid ceramidase J Biol Chem 283 2008 11253 11259
185. K. Ferlinz, G. Kopal, K. Bernardo, T. Linke, J. Bär, and B. Breiden Human acid ceramidase: processing, glycosylation, and lysosomal targeting J Biol Chem 276 2001 35352 35360
186. H. Schulze, U. Schepers, and K. Sandhoff Overexpression and mass spectrometry analysis of mature human acid ceramidase Biol Chem 388 2007 1333 1343
187. K. Bernardo, R. Hurwitz, T. Zenk, R.J. Desnick, K. Ferlinz, and E.H. Schuchman Purification, characterization, and biosynthesis of human acid ceramidase J Biol Chem 270 1995 11098 11102
188. B.F. Cravatt, and A.H. Lichtman Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system Curr Opin Chem Biol 7 2003 469 475
189. S. Vandevoorde, K. Tsuboi, N. Ueda, K.-O. Jonsson, C.J. Fowler, and D.M. Lambert Esters, retroesters, and a retroamide of palmitic acid: pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase J Med Chem 46 2003 4373 4376
190. K. Tsuboi, C. Hilligsmann, S. Vandevoorde, D.M. Lambert, and N. Ueda N-Cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase Biochem J 379 2004 99 106
191. C. Saturnino, S. Petrosino, A. Ligresti, C. Palladino, G.D. Martino, and T. Bisogno Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase Bioorg Med Chem Lett 20 2010 1210 1213
192. C. Solorzano, C. Zhu, N. Battista, G. Astarita, A. Lodola, and S. Rivara Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation Proc Natl Acad Sci USA 106 2009 20966 20971
193. E. Holtzman Lysosomes 1989 Springer New York
194. D.E. Sleat, M.C. Della Valle, H. Zheng, D.F. Moore, and P. Lobel The mannose 6-phosphate glycoprotein proteome J Proteome Res 7 2008 3010 3021
195. T. Lübke, P. Lobel, and D.E. Sleat Proteomics of the lysosome Biochim Biophys Acta 1793 2009 625 635
196. A.H. Lichtman, C.C. Shelton, T. Advani, and B.F. Cravatt Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia Pain 109 2004 319 327
197. B.F. Cravatt, A. Saghatelian, E.G. Hawkins, A.B. Clement, M.H. Bracey, and A.H. Lichtman Functional disassociation of the central and peripheral fatty acid amide signaling systems Proc Natl Acad Sci USA 101 2004 10821 10826
198. F. Massa, G. Marsicano, H. Hermann, A. Cannich, K. Monory, and B.F. Cravatt The endogenous cannabinoid system protects against colonic inflammation J Clin Invest 113 2004 1202 1209
199. D. Fegley, S. Gaetani, A. Duranti, A. Tontini, M. Mor, and G. Tarzia Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation J Pharmacol Exp Ther 313 2005 352 358
200. J. Liu, S. Bátkai, P. Pacher, J. Harvey-White, J.A. Wagner, and B.F. Cravatt Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-κB independently of platelet-activating factor J Biol Chem 278 2003 45034 45039
201. M.D. Jhaveri, D. Richardson, D.A. Kendall, D.A. Barrett, and V. Chapman Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain J Neurosci 26 2006 13318 13327
202. 1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia Neuroscience 129 2004 743 750
203. L. Faure, D. Coulon, J. Laroche-Traineau, M. Le Guedard, J.M. Schmitter, and E. Testet Discovery and characterization of an Arabidopsis thaliana N-acylphosphatidylethanolamine synthase J Biol Chem 284 2009 18734 18741